Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Witt

Showing results (141-150 of 242) with videos related to

Pageof 25
Sort By:
Acta Neuropathologica|April 22, 2010
Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettesAndrey Korshunov, Marc Remke, Marco Gessi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 21, 2022
Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registryJonas Ecker, Florian Selt, Dominik Sturm, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2023
Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84]Jonas Ecker, Florian Selt, Dominik Sturm, et al.
Cancer Research|January 15, 2014
GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3Johannes Fabian, Marco Lodrini, Ina Oehme, et al.
The Lancet. Oncology|August 4, 2023
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 studyShubham Pant, Martin Schuler, Gopa Iyer, et al.
Acta Neuropathologica|December 3, 2011
MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastomaAlfa H C Bai, Till Milde, Marc Remke, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2016
Implementation of mechanism of action biology-driven early drug development for children with cancerAndrew D J Pearson, Ralf Herold, Raphaël Rousseau, et al.
Oncotarget|December 22, 2016
Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testingFlorian Selt, Juliane Hohloch, Thomas Hielscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201Jordan R Hansford, Gauthier Bouche, Vijay Ramaswamy, et al.
Acta Neuropathologica|July 7, 2019
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusionsDamian Stichel, Daniel Schrimpf, Belén Casalini, et al.
Pageof 25

Showing results (141-150 of 242) with videos related to

Sort By:
Pageof 25
Acta Neuropathologica|April 22, 2010
Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettesAndrey Korshunov, Marc Remke, Marco Gessi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 21, 2022
Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registryJonas Ecker, Florian Selt, Dominik Sturm, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2023
Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84]Jonas Ecker, Florian Selt, Dominik Sturm, et al.
Cancer Research|January 15, 2014
GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3Johannes Fabian, Marco Lodrini, Ina Oehme, et al.
The Lancet. Oncology|August 4, 2023
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 studyShubham Pant, Martin Schuler, Gopa Iyer, et al.
Acta Neuropathologica|December 3, 2011
MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastomaAlfa H C Bai, Till Milde, Marc Remke, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2016
Implementation of mechanism of action biology-driven early drug development for children with cancerAndrew D J Pearson, Ralf Herold, Raphaël Rousseau, et al.
Oncotarget|December 22, 2016
Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testingFlorian Selt, Juliane Hohloch, Thomas Hielscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201Jordan R Hansford, Gauthier Bouche, Vijay Ramaswamy, et al.
Acta Neuropathologica|July 7, 2019
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusionsDamian Stichel, Daniel Schrimpf, Belén Casalini, et al.
Pageof 25